Inflammatory Breast Neoplasms
"Inflammatory Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.
| Descriptor ID |
D058922
|
| MeSH Number(s) |
C04.588.180.576 C17.800.090.500.576
|
| Concept/Terms |
Inflammatory Breast Neoplasms- Inflammatory Breast Neoplasms
- Breast Neoplasm, Inflammatory
- Breast Neoplasms, Inflammatory
- Inflammatory Breast Neoplasm
- Neoplasm, Inflammatory Breast
- Neoplasms, Inflammatory Breast
- Inflammatory Breast Cancer (IBC)
- Inflammatory Breast Carcinoma
- Breast Carcinoma, Inflammatory
- Breast Carcinomas, Inflammatory
- Carcinoma, Inflammatory Breast
- Carcinomas, Inflammatory Breast
- Inflammatory Breast Carcinomas
- Inflammatory Breast Cancer
- Breast Cancer, Inflammatory
- Breast Cancers, Inflammatory
- Cancer, Inflammatory Breast
- Cancers, Inflammatory Breast
- Inflammatory Breast Cancers
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Breast Neoplasms".
This graph shows the total number of publications written about "Inflammatory Breast Neoplasms" by people in this website by year, and whether "Inflammatory Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 8 | 0 | 8 |
| 2011 | 9 | 2 | 11 |
| 2012 | 5 | 1 | 6 |
| 2013 | 10 | 1 | 11 |
| 2014 | 11 | 1 | 12 |
| 2015 | 16 | 0 | 16 |
| 2016 | 8 | 0 | 8 |
| 2017 | 15 | 1 | 16 |
| 2018 | 11 | 1 | 12 |
| 2019 | 3 | 0 | 3 |
| 2020 | 10 | 0 | 10 |
| 2021 | 21 | 0 | 21 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammatory Breast Neoplasms" by people in Profiles.
-
Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH, Nead KT. Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US. JAMA Netw Open. 2022 02 01; 5(2):e2148021.
-
Ueno NT, Alexander A. "Why and What" for the optimal management of inflammatory breast cancer. Chin Clin Oncol. 2021 Dec; 10(6):54.
-
Le-Petross HT, Balema W, Woodward WA. Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review. Chin Clin Oncol. 2021 Dec; 10(6):58.
-
Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol. 2021 Dec; 10(6):57.
-
Corrigan KL, Woodward WA, Stauder MC. How should radiation be done for inflammatory breast cancer patients?-a narrative review of modern literature. Chin Clin Oncol. 2021 Dec; 10(6):60.
-
Patel MM, Le-Petross HT. Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review. Chin Clin Oncol. 2021 Dec; 10(6):56.
-
Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, Vivas-Mejía P, Woodward WA, Debeb BG. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol. 2021 10; 15(10):2752-2765.
-
Santiago-Sánchez GS, Noriega-Rivera R, Hernández-O'Farrill E, Valiyeva F, Quiñones-Diaz B, Villodre ES, Debeb BG, Rosado-Albacarys A, Vivas-Mejía PE. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. Int J Mol Sci. 2021 Aug 10; 22(16).
-
Adesoye T, Lucci A. Current Surgical Management of Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Oct; 28(10):5461-5467.
-
Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med. 2021 09; 10(18):6261-6272.